GlaxoSmithKline's newest TV ads for Trelegy (screenshot above) embrace the realities of living with COPD.

November 22, 2021 08:05 AM EST

GlaxoSmithKline's Trelegy ad change-up spurs better relatability with COPD patients — and more doctor conversations

Beth Snyder Bulik

Senior Editor

When GlaxoSmithKline launched its first campaign for three-drug combo Trelegy inhaler, it used a catchy “1-2-3” pop song. A customized version of a 1970s Jackson …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

GlaxoSmithKline's Trelegy ad change-up spurs better relatability with COPD patients — and more doctor conversations

Beth Snyder Bulik

Senior Editor

Sign up to read this article for free.

Trump names Johns Hopkins researcher Marty Makary to lead the FDA; also names CDC, Surgeon General picks

FDA approves BridgeBio's heart disease drug, setting up competition with Pfizer, Alnylam

Drug or biologic? An Eli Lilly lawsuit could impact weight loss drug compounders

Patient dies in Neurogene's Rett syndrome study

Surrounded by AI bio giants, tiny startup Nabla Bio makes de novo antibodies look more like drugs

Are programs with compounded GLP-1s safe for your population?

Glax­o­SmithK­line's Trel­e­gy ad change-up spurs bet­ter re­lata­bil­i­ty with COPD pa­tients — and more doc­tor con­ver­sa­tions

Beth Snyder Bulik

Senior Editor

Sign up to read this article for free.

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

GlaxoSmithKline's Trelegy ad change-up spurs better relatability with COPD patients — and more doctor conversations

Trump names Johns Hopkins researcher Marty Makary to lead the FDA; also names CDC, Surgeon General picks

FDA approves BridgeBio's heart disease drug, setting up competition with Pfizer, Alnylam

Drug or biologic? An Eli Lilly lawsuit could impact weight loss drug compounders

Patient dies in Neurogene's Rett syndrome study

Surrounded by AI bio giants, tiny startup Nabla Bio makes de novo antibodies look more like drugs

Are programs with compounded GLP-1s safe for your population?